The Federal Trade Commission in October brought its  long-anticipated  lawsuit against the nation’s three biggest ...
Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
The largest increases were seen in low-income and middle-income countries in southeast Asia, south Asia, the Middle East and north Africa, and Latin America and the Caribbean. The country with the ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...